Showing results (301-310 of 315) with videos related to

Sort By:
Pageof 32
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Brachytherapy for early endometrial carcinoma: a comparative study with long-term follow-upP. G. Rose, W. K. Tak, T. J. Fitzgerald, et al.
Journal of the National Cancer Institute|July 6, 2000
Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53B A Werness, P Parvatiyar, S J Ramus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Phase I study of paclitaxel, carboplatin, and increasing days of prolonged oral etoposide in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group studyP G Rose, M Rodriguez, S Waggoner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancerA N Gordon, C O Granai, P G Rose, et al.
American Journal of Clinical Oncology|February 1, 1997
A phase II trial of edatrexate in previously treated squamous cell cervical cancer: a Gynecologic Oncology Group studyE R Broun, K A Iseminger, P G Rose, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 1993
Primary radiation therapy for endometrial carcinoma: a case controlled studyP G Rose, S Baker, M Kern, et al.
The New England Journal of Medicine|April 15, 1999
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancerP G Rose, B N Bundy, E B Watkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovarian carcinoma: a gynecologic oncology group studyP M Fracasso, M F Brady, D H Moore, et al.
Pageof 32